BioNTech SE (BNTX) Operating Income (2018 - 2026)
BioNTech SE (BNTX) posted Operating Income of -$1.1 billion for Q2 2026, compared with -$567.22 million a year earlier.
Powered by 
Analysis
BioNTech SE (BNTX) Operating Income (2018 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Operating Income at BioNTech SE was -$2.33 billion; for FY2025, it was -$1.64 billion.
- In prior years, BioNTech SE's Operating Income was -$1.4 billion in FY2024, $742.83 million in FY2023 (-94.2%), $12.9 billion in FY2022 (-26.2%) and $17.48 billion in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Operating Income in data going back to Q3 2018.
- The strongest year-over-year quarter for Operating Income in the past five years was Q1 2022, with growth of 166.0%; the weakest was Q3 2023, with a decline of 96.7%.
- According to Business Quant data, Operating Income for the three prior quarters was -$793.18 million (Q1 2026), -$375.75 million (Q4 2025) and -$54.83 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.27 Bn |
| 10 | BioNTech SE | 24.50 Bn | -34.86 Bn | 10.00 Mn | -1.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.10 Bn |
| Mar 31, 2026 | -793.18 Mn |
| Dec 31, 2025 | -375.75 Mn |
| Sep 30, 2025 | -54.83 Mn |
| Jun 30, 2025 | -567.22 Mn |
| Mar 31, 2025 | -561.81 Mn |
| Dec 31, 2024 | 158.79 Mn |
| Sep 30, 2024 | 11.53 Mn |
| Jun 30, 2024 | -1.04 Bn |
| Mar 31, 2024 | -551.00 Mn |
| Dec 31, 2023 | 566.16 Mn |
| Sep 30, 2023 | 79.58 Mn |
| Jun 30, 2023 | -613.39 Mn |
| Mar 31, 2023 | 702.39 Mn |
| Dec 31, 2022 | 3.36 Bn |
| Sep 30, 2022 | 2.41 Bn |
| Jun 30, 2022 | 2.36 Bn |
| Mar 31, 2022 | 5.33 Bn |
| Dec 31, 2021 | 5.38 Bn |
| Sep 30, 2021 | 5.57 Bn |
API Access
BioNTech SE Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=BNTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "BNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=BNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();